Stability predicts treatment success for vitiligo

Stability predicts treatment success for vitiligo
In patients with vitiligo, a depigmenting disorder characterized by loss of melanocytes from the epidermis, melanocyte transplantation is more likely to be successful in patients whose disease has been stable for longer periods, according to a study published online Feb. 13 in the British Journal of Dermatology.

(HealthDay) -- In patients with vitiligo, a depigmenting disorder characterized by loss of melanocytes from the epidermis, melanocyte transplantation is more likely to be successful in patients whose disease has been stable for longer periods, according to a study published online Feb. 13 in the British Journal of Dermatology.

A. Rao, and colleagues from the All India Institute of Medical Sciences in New Delhi, divided 33 with generalized affecting less than 10 percent of their into three clinical stability groups: stability greater than three months but less than one year (Group 1), at least one year but less than two years (Group 2), and at least two years (Group 3). Melanocyte transplantation was done on a single patch, and blood was drawn for catalase in patients and 10 healthy controls. Immunohistochemistry was analyzed on the day of transplant.

As defined by ≥75 percent repigmentation at six months, the researchers found that the success rate for melanocyte transplantation was 0 percent for Group 1, 37.5 percent for Group 2, and 77.8 percent for Group 3. Compared with nonresponders, the median period of stability was significantly longer in responders. There were no significant differences in catalase levels in all three groups of patients, in patients versus healthy controls, or in responders versus non-responders. Compared with responders, the percentage of CD8 and CD45RO cells were significantly higher in the nonresponders.

"Along with clinical stability, proportion of CD8 and CD45RO cells in skin biopsies might help in determining stability of disease and thereby predicting success of transplantation," Rao and colleagues conclude.


Explore further

Skin transplant offers new hope to vitiligo patients

More information: Abstract
Full Text (subscription or payment may be required)
Journal information: British Journal of Dermatology

Copyright © 2012 HealthDay. All rights reserved.

Citation: Stability predicts treatment success for vitiligo (2012, February 23) retrieved 18 September 2019 from https://medicalxpress.com/news/2012-02-stability-treatment-success-vitiligo.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more